FEATURED/ARCHIVES (29/04/24)
Physical Exercise and Metformin in Gestational Obesity and Prevention on Gestational Diabetes Mellitus: A Systematic Review · January 2020
Articles
Revista Brasileira de Saude Materno Infantil
Risperidone-Induced Obesity in Children and Adolescents with Autism Spectrum Disorder: Genetic and Clinical Risk Factors · November 2020
Articles
Frontiers in Pharmacology
Body Mass Index as a Determinant of Clozapine Plasma Concentrations: A Pharmacokinetic-Based Hypothesis · February 2021
Abstracts
Journal of Psychopharmacology
A Meta-Analysis Comparing Short-Term Weight and Cardiometabolic Changes between Olanzapine/Samidorphan and Olanzapine · April 2021
Articles
Scientific Reports
The Association between BDNF Levels and Risperidone-Induced Weight Gain Is Dependent on the BDNF Val66Met Polymorphism in Antipsychotic-Naive First Episode Schizophrenia Patients: A 12-Week Prospective Study · September 2021
Articles
Translational Psychiatry
Energy Intake as a Short‐Term Biomarker for Weight Loss in Adults with Obesity Receiving Liraglutide: A Randomized Trial · February 2021
Articles
Obesity Science and Practice
Probiotics Plus Dietary Fiber Supplements Attenuate Olanzapine-Induced Weight Gain in Drug-Naive First-Episode Schizophrenia Patients: Two Randomized Clinical Trials · May 2022
Articles
Schizophrenia Bulletin
Impacts of Metabolic Disruption, Body Mass Index and Inflammation on Cognitive Function in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine · February 2024
Articles
Annals of General Psychiatry
An Open-Label Trial on the Efficacy and Tolerability of Naltrexone/Bupropion SR for Treating Altered Eating Behaviours and Weight Loss in Binge Eating Disorder · April 2020
Abstracts
Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity
A Double-Blind, Placebo-Controlled Trial of Bupropion Add-On to Olanzapine or Risperidone in Overweight Individuals with Schizophrenia · November 2021
Abstracts
Journal of Clinical Psychopharmacology
Metabolic Biomarkers of Risperidone-Induced Weight Gain in Drug-Naive Patients with Schizophrenia · April 2023
Articles
Frontiers in Psychiatry
Metformin Attenuates Liver Fat Content: Finding from Schizophrenia Patients with Olanzapine-Induced Weight Gain · February 2020
Articles
Clinical Psychopharmacology and Neuroscience
Naltrexone + Bupropion Combination for the Treatment of Binge-Eating Disorder with Obesity: A Randomized, Controlled Pilot Study · November 2020
Articles (Manuscripts-Versions)
PubMed Central>Clinical Therapeutics
A Systematic Review of Clinical Trials on Lumateperone and Its Effects on Body Weight · September 2022
Abstracts
Journal of Clinical Psychopharmacology
Psychiatric Safety and Weight Loss Efficacy of Naltrexone/Bupropion as Add-On to Antidepressant Therapy in Patients with Obesity or Overweight · April 2021
Articles
Journal of Affective Disorders
Antioxidant Enzymes and Weight Gain in Drug-Naive First-Episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study · August 2022
Articles
NCBI>Current Neuropharmacology
Effect of Bifidobacterium on Olanzapine-Induced Body Weight and Appetite Changes in Patients with Psychosis · May 2021
Abstracts
Psychopharmacology
Mediterranean Diet and Naltrexone/Bupropion Treatment for Weight Loss in Overweight and Obese Breast Cancer Survivors and Non-Cancer Participants: A Pilot Randomized Controlled Trial · September 2020
Articles
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Psychiatric Adverse Events Associated with Semaglutide, Liraglutide and Tirzepatide: A Pharmacovigilance Analysis of Individual Case Safety Reports Submitted to the Eudravigilance Database · January 2024
Articles
International Journal of Clinical Pharmacy